<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>775</number>
    <updateDate>2025-04-21T12:24:17Z</updateDate>
    <updateDateIncludingText>2025-04-21T12:24:17Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2023-03-14</introducedDate>
    <congress>118</congress>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2023-03-14T19:29:56Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>PATIENT Act of 2023</title>
        <congress>118</congress>
        <number>3561</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2024-12-17</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Expanding Access to Low-Cost Generics Act of 2023</title>
        <congress>118</congress>
        <number>1114</number>
        <type>S</type>
        <latestAction>
          <actionDate>2023-06-22</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 108.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.</title>
        <congress>118</congress>
        <number>3839</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-06-09</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Lower Costs, More Transparency Act</title>
        <congress>118</congress>
        <number>5378</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-12-11</actionDate>
          <text>Motion to reconsider laid on the table Agreed to without objection.</text>
          <actionTime>19:13:20</actionTime>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2023-03-14</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2023-03-14</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>H001076</bioguideId>
        <fullName>Sen. Hassan, Margaret Wood [D-NH]</fullName>
        <firstName>Maggie</firstName>
        <lastName>Hassan</lastName>
        <party>D</party>
        <state>NH</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>P000603</bioguideId>
        <fullName>Sen. Paul, Rand [R-KY]</fullName>
        <firstName>Rand</firstName>
        <lastName>Paul</lastName>
        <party>R</party>
        <state>KY</state>
        <sponsorshipDate>2023-03-14</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001310</bioguideId>
        <fullName>Sen. Braun, Mike [R-IN]</fullName>
        <firstName>Mike</firstName>
        <lastName>Braun</lastName>
        <party>R</party>
        <state>IN</state>
        <sponsorshipDate>2023-03-28</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H000273</bioguideId>
        <fullName>Sen. Hickenlooper, John W. [D-CO]</fullName>
        <firstName>John</firstName>
        <lastName>Hickenlooper</lastName>
        <party>D</party>
        <state>CO</state>
        <middleName>W.</middleName>
        <sponsorshipDate>2023-04-25</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
          <updateDate>2023-10-11T19:30:35Z</updateDate>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
          <updateDate>2023-10-11T19:30:35Z</updateDate>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2023-10-11T19:30:35Z</updateDate>
        </item>
        <item>
          <name>Prescription drugs</name>
          <updateDate>2023-10-11T19:30:35Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-04-03T18:15:14Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-03-14</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2023-10-02T19:37:32Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Increasing Transparency in Generic Drug Applications Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill requires the Food and Drug Administration (FDA) to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why). The FDA must also update or publish guidance on how it makes such determinations.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Increasing Transparency in Generic Drug Applications Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Increasing Transparency in Generic Drug Applications Act</title>
        <updateDate>2024-07-24T15:23:21Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Increasing Transparency in Generic Drug Applications Act</title>
        <updateDate>2024-05-24T13:41:41Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>A bill to provide for increased transparency in generic drug applications.</title>
        <updateDate>2023-03-30T02:43:49Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2023-03-14T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s775is/xml/BILLS-118s775is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-03-14</actionDate>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
